Infiniti Medical Joins Forces with CIMA Animal Health
Today, an important milestone in the veterinary healthcare sector has been achieved as Infiniti Medical, renowned for its advancements in veterinary technology, has been officially acquired by CIMA Animal Health, part of the Creative Science portfolio. This transaction marks a significant step forward in the industry, emphasizing the ongoing commitment to enhancing care for animals and the veterinary professionals dedicated to their well-being.
Significance of the Acquisition
The acquisition signifies more than just a business move; it showcases the unyielding dedication of Creative Science to delivering top-tier veterinary solutions aimed at improving patient outcomes. With CIMA Animal Health leading this strategic integration, the combined resources of both companies promise to propel forward-thinking innovations within the veterinary field.
Expanding Horizons in Veterinary Medicine
Infiniti Medical is a pioneer in creating groundbreaking technologies that focus on interventional radiology, advanced diagnostics, and surgical assist systems. This acquisition allows for the merging of innovative ideas and the collective expertise of two industry leaders, ultimately leading to enhanced resources available to practitioners globally.
Innovative Solutions for Veterinarians
Founded in the heart of Silicon Valley, Infiniti Medical has consistently pushed the envelope regarding what is achievable in veterinary medicine. Their strong emphasis on innovation is evident through various product lines, including their proprietary Vet Stent technology. Furthermore, their subsidiary, Orthomed, has earned accolades for providing high-quality orthopedic solutions that have set higher standards within the veterinary surgical community.
Leaders in the Field Speak Out
Lynn Snodgrass, CEO of CIMA Animal Health, shared her excitement about this merger, stating, "This acquisition represents an exciting opportunity to expand our impact on veterinary medicine. By joining forces with Infiniti Medical and Orthomed, we can accelerate innovation and provide even greater value to veterinary professionals worldwide." Such statements highlight a shared vision amongst the leadership teams of both companies, as they look towards a collaborative future.
Future Developments
Under the banner of Creative Science, Infiniti Medical will have access to a broader platform, enabling further investment in technology and expansion of their product offerings. Jared Finegold, CEO of Infiniti Medical, remarked on the partnership, noting that their foundational belief in transformative veterinary solutions aligns perfectly with Creative Science's mission. This union will allow them to continue to grow and influence the landscape of veterinary care.
A Legacy of Innovation
Craig Lawson, Managing Director at Hyde Park Capital, noted the significance of this merger. He stated, "Infiniti Medical and Orthomed have built an outstanding legacy of innovation in veterinary medicine. This partnership with Creative Science is a natural fit and positions these brands for even greater success." The encouragement from investment partners demonstrates widespread confidence in the collaborative capabilities of both entities.
About Infiniti Medical
Infiniti Medical stands as a beacon of innovation in the veterinary medical technology sector. Specializing in interventional radiology and soft tissue surgery, the company is committed to enhancing healthcare outcomes through cutting-edge solutions and educational initiatives. Through its exceptional product range, including the pioneering Vet Stent technology and high-quality implants via Orthomed, Infiniti Medical aims to continually raise the standards for veterinary healthcare.
About Creative Science
Creative Science has emerged as a leader in veterinary health solutions, born from the unification of multiple respected companies. Their commitment to research and development ensures that veterinarians and animal caregivers have access to the vital tools required for comprehensive animal care, promoting health and wellness across various species. This acquisition amplifies their goal of bridging critical gaps in veterinary medicine.
About Hyde Park Capital
With a focus on tailored investment strategies, Hyde Park Capital serves as a trusted advisor for both mergers and acquisitions. Their extensive background in capital markets spans various sectors, including technology, healthcare, and consumer services. Based in Tampa, Florida, Hyde Park Capital remains committed to supporting prosperous founder and family-owned enterprises in navigating financial landscapes.
Frequently Asked Questions
What is the significance of the acquisition of Infiniti Medical?
The acquisition by CIMA Animal Health allows for the integration of innovative technologies and expanded resources, enhancing veterinary care globally.
Who are the leaders involved in this acquisition?
Lynn Snodgrass is the CEO of CIMA Animal Health, while Jared Finegold leads Infiniti Medical. Their expertise drives the vision for enhanced veterinary solutions.
What are some technologies developed by Infiniti Medical?
Infiniti Medical specializes in pioneering veterinary devices, including advanced diagnostic systems and the Vet Stent technology.
How does this merger affect veterinary professionals?
This merger promises to enhance the offerings available to veterinary professionals, allowing for improved care and efficiency in clinical settings.
What role does Hyde Park Capital play in this process?
Hyde Park Capital acted as an exclusive financial advisor to Infiniti Medical, facilitating this strategic move and ensuring a seamless transition for both parties.
